Seeking Alpha

Cambrex (CBM -1%) and Dow Chemical (DOW -0.9%) sign an agreement for CBM to contract manufacture...

Cambrex (CBM -1%) and Dow Chemical (DOW -0.9%) sign an agreement for CBM to contract manufacture DOW's Hydroxypropyl Methylcellulose Acetate Succinate for use in drug solubility enhancement. The agreement is the final realization of a solubilization partnership that Dow and Bend Research announced in October 2012. Construction has already begun on the new operational facility at Cambrex Karlskoga with commercial product availability set for year-end 2013.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs